N-Glycosylation in the Receptor Binding Domain serves as aggregation gatekeeper of the SARS CoV2 Spike glycoprotein folding
Journal of Biological Chemistry · 2026-10 · 113681
DOI: 10.1016/j.jbc.2026.113681 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Biological Chemistry, 2026-10. Verfasst von Anita Kumari und 1 weiteren Autor:innen. Beteiligte Einrichtung: G.N. Ramachandran Protein Centre, CSIR-Institute of Microbial Technology, Chandigarh, India; Academy of Scientific and Innovation Research (AcSIR), G…. Die Arbeit nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: CSIR-Institute of Microbial Technology.
Abstract (Originalsprache)
The SARS CoV2 Spike is a multi-domain surface glycoprotein that binds human ACE2 via its receptor binding domain (RBD-CoV2) initiating the viral infection. Several aggregation prone regions are predicted in the Spike-CoV2 sequence. Here, we describe the intrinsic aggregation feature and characterization of RBD-CoV2 aggregates of the Wuhan variant in the context of its folding. In agreement with its predicted aggregation-prone nature, recombinant RBD-CoV2 in E. coli exclusively forms inclusion bodies that binds Thioflavin S dye. In vitro refolding of pure denatured RBD-CoV2 results in extensive aggregation yielding very low amounts of soluble functional protein. The RBD-CoV2 in vitro aggregates contain β-sheet structure as revealed by the Raman spectral analysis, bind amyloid-specific AmyTracker 630 and ProteoStat dyes, and have clustered sphere-like morphology. Similarly, the non-glycosylated RBD-CoV2 missing the N-glycan on Asn331 and Asn343, an equivalent to EcRBD, is not secreted, but retained in the endoplasmic reticulum of HEK293T cells. The ProteoStat dye binding indicates intracellular accumulation of the N-glycan RBD variants as amyloids in live cells. Furthermore, selective removal of both RBD N-glycans results in severe secretion defect of the Spike ectodomain, and markedly reduced syncytia formation in cells expressing glycan variants of membrane-bound Spike. Our study thus conclusively demonstrates that the essential role of RBD N-glycans is to prevent misfolding and aggregation of RBD-CoV2 and Spike-CoV2. The presence of N-glycan at either one of the two Asn in RBD significantly reduces misfolding of the full length Spike-CoV2, and the absence of both glycans results in RBD-CoV2 to form amyloids.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- G.N. Ramachandran Protein Centre, CSIR-Institute of Microbial Technology, Chandigarh, India; Academy of Scientific and Innovation Research (AcSIR), Ghaziabad, India.
- G.N. Ramachandran Protein Centre, CSIR-Institute of Microbial Technology, Chandigarh, India; Academy of Scientific and Innovation Research (AcSIR), Ghaziabad, India. Electronic address: beena.krishnan@csir.res.in.
Förderung
- CSIR-Institute of Microbial Technology
Zitieren
APA
Kumari, A., & Krishnan, B. (2026). N-Glycosylation in the Receptor Binding Domain serves as aggregation gatekeeper of the SARS CoV2 Spike glycoprotein folding. Journal of Biological Chemistry, 113681. https://doi.org/10.1016/j.jbc.2026.113681
Vancouver
Kumari A, Krishnan B. N-Glycosylation in the Receptor Binding Domain serves as aggregation gatekeeper of the SARS CoV2 Spike glycoprotein folding. Journal of Biological Chemistry. 2026:113681. doi:10.1016/j.jbc.2026.113681
BibTeX
@article{Kumari2026,
author = {Kumari, Anita and Krishnan, Beena},
title = {N-Glycosylation in the Receptor Binding Domain serves as aggregation gatekeeper of the SARS CoV2 Spike glycoprotein folding},
journal = {Journal of Biological Chemistry},
year = {2026},
pages = {113681},
doi = {10.1016/j.jbc.2026.113681}
}
EUVIMED